Free Cash Flow for AstraZeneca (AZN)
Free Cash Flow for AstraZeneca (AZN): headline value $10.57B · YoY +61.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingFree Cash FlowSwitch metric
Latest period
$10.57B
YoY change
+61.7%
5Y CAGR
+39.9%
Peak year (2025)
$11.77B
Latest annual
$11.77B
Free Cash Flow history chart for AstraZeneca (AZN) from 1990 to 2025
Free Cash Flow history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $11.77B | +61.7% | ||
| 2024 | $7.28B | +10.8% | ||
| 2023 | $6.57B | -9.3% | ||
| 2022 | $7.24B | +92.3% | ||
| 2021 | $3.76B | +71.6% | ||
| 2020 | $2.19B | +330.8% | ||
| 2019 | $509.00M | -59.2% | ||
| 2018 | $1.25B | -36.3% | ||
| 2017 | $1.96B | +6.9% | ||
| 2016 | $1.83B | +241.6% | ||
| 2015 | $536.00M | -87.6% | ||
| 2014 | $4.31B | -19.4% | ||
| 2013 | $5.34B | +129.4% | ||
| 2012 | $2.33B | -64.3% | ||
| 2011 | $6.52B | -21.0% | ||
| 2010 | $8.26B | -5.9% | ||
| 2009 | $8.78B | +86.7% | ||
| 2008 | $4.70B | -19.3% | ||
| 2007 | $5.83B | -8.2% | ||
| 2006 | $6.35B | +10.2% | ||
| 2005 | $5.76B | +26.9% | ||
| 2004 | $4.54B | +112.8% | ||
| 2003 | $2.13B | -38.9% | ||
| 2002 | $3.49B | +687.0% | ||
| 2001 | $443.83M | -49.3% | ||
| 2000 | $875.25M | -147.5% | ||
| 1999 | -$1.84B | -5387.5% | ||
| 1998 | $34.86M | -521.7% | ||
| 1997 | -$8.27M | -105.5% | ||
| 1996 | $148.99M | -3.6% | ||
| 1995 | $154.52M | +16.3% | ||
| 1994 | $132.89M | -45.2% | ||
| 1993 | $242.59M | -221.2% | ||
| 1992 | -$200.20M | -267.2% | ||
| 1991 | $119.76M | -55.0% | ||
| 1990 | $266.19M | — |
Free Cash Flow values are taken from AstraZeneca's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
AstraZeneca (AZN) most recent annual free cash flow stands at $11.77B (2025) – surged 61.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AstraZeneca free cash flow compounded at +39.9% per year, sustaining 2 straight years of year-over-year growth.
The dataset's maximum free cash flow sits at $11.77B (2025); the minimum reading of -$1.84B dates to 1999.
AstraZeneca (AZN) sits 6th of 8 Healthcare peers we track on this metric, against a peer median of $14.22B.
AstraZeneca Free Cash Flow by Year
AstraZeneca Free Cash Flow 2025: $11.77B
AstraZeneca free cash flow in 2025 was $11.77B, surged 61.7% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Free Cash Flow 2024: $7.28B
AstraZeneca free cash flow in 2024 was $7.28B, grew 10.8% from 2023.
AstraZeneca Free Cash Flow 2023: $6.57B
AstraZeneca free cash flow in 2023 was $6.57B, declined 9.3% below 2022.
AstraZeneca Free Cash Flow 2022: $7.24B
AstraZeneca free cash flow in 2022 was $7.24B, surged 92.3% from 2021.
AstraZeneca Free Cash Flow 2021: $3.76B
AstraZeneca free cash flow in 2021 was $3.76B.
See more financial history for AstraZeneca (AZN).
Sector peers — Free Cash Flow
Companies in the same sector as AstraZeneca, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.29B | Healthcare |
Frequently asked questions
What is AstraZeneca's free cash flow?
Latest reported free cash flow for AstraZeneca (AZN) is $10.57B (period ending December 31, 2025).
How has AstraZeneca free cash flow changed year-over-year?
AstraZeneca (AZN) free cash flow changed +61.7% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca free cash flow?
AstraZeneca (AZN) free cash flow compound annual growth rate is +39.9% over the most recent 5 years available.
When did AstraZeneca free cash flow hit its highest annual value?
AstraZeneca free cash flow reached its highest annual value of $11.77B in 2025.
What was AstraZeneca free cash flow in 2024?
AstraZeneca (AZN) free cash flow in 2024 was $7.28B.
What was AstraZeneca free cash flow in 2025?
AstraZeneca (AZN) free cash flow in 2025 was $11.77B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.